BioSpace News Archive

The U.S. Food and Drug Administration and the Federal Trade Commission today signed a joint statement regarding enhanced collaboration in support of a robust marketplace for biological products, including the critical adoption of biosimilars and interchangeable products.

Acoer, developer of blockchain-enabled applications, announced that it is helping its healthcare and life sciences clients to easily track and visualize the Coronavirus outbreak with its HashLog data visualization engine.

Thought leaders in cancer cell and gene therapy research will share the latest advances, address the greatest challenges and showcase the most innovative programs in progress today.

Endologix, Inc., a developer and marketer of innovative treatments for aortic disorders, announced the grant of an inducement equity award to a newly hired employee.

Genprex, Inc., a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, announced that the Company will present at the Noble Capital Markets 16th Annual Investor Conference on Monday, February 17, 2020 at 1:30 p.m. EST.

Caladrius Biosciences, Inc., a late-stage therapeutics development biopharmaceutical company pioneering advancements of cell therapies in select cardiovascular and autoimmune diseases, announced that David J. Mazzo, PhD, President and Chief Executive Officer of the Caladrius, will present a company overview at the following conferences in February:.

Brings to Portola 20 Years of Clinical Development and Approval Experience

Lantheus Holdings, Inc. (NASDAQ: LNTH) (“Lantheus” or the “Company”), parent company of Lantheus Medical Imaging, Inc. (“LMI”), a leader in the development, manufacture and commercialization of innovative diagnostic imaging agents and products, today announced topline results for the BENEFIT 1 Left Ventricular Ejection Fraction (“LVEF”) clinical trial.

Neogen Corporation (NASDAQ: NEOG) announced today that it has acquired the United Kingdom -based Abtek Biologicals Limited — a developer and supplier of culture media supplements and microbiology technologies that increases Neogen’s current solutions portfolio.

On the eve of World Cancer Day, the Canadian Cancer Society (CCS) and Prostate Cancer Canada (PCC) have finalized their amalgamation